European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections
Fostering synergies among the EU European Union (European Union) Member States by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI.
EU European Union (European Union) JAMRAI ended in 2021. The Ministry of Health, Welfare and Sport of the Netherlands led Work Package 5 (WP5), in collaboration with RIVM and the Health and Youth Care Inspectorate (IGJ). WP5 involved the implementation of One Health national strategies and national action plans for AMR. The goal was to support Member States in implementing the provisions laid down in the EU “Council Conclusions on the next steps under a One Health approach to combat antimicrobial resistance”. This was done by fostering collaboration between EU Member States, the European Commission and relevant international institutions.
In 2018 and 2019, the 13 participating countries visited each other, exchanging tips and improvements on the approach to antimicrobial resistance. During these multi-day visits, both the humane and veterinary approaches to antimicrobial resistance were discussed. Country visits function as an opportunity to exchange best practices and provide an outsider’s point of view. They set up a country-to-country peer review system. This infographic presents the most relevant topics to address for each country.
All EU JAMRAI results and recommendations are available online.
Pita Spruijt of RIVM was involved in the EU JAMRAI.